Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 7
1994 19
1995 29
1996 27
1997 40
1998 51
1999 47
2000 44
2001 37
2002 33
2003 38
2004 41
2005 38
2006 51
2007 31
2008 44
2009 44
2010 30
2011 32
2012 23
2013 32
2014 25
2015 23
2016 15
2017 13
2018 18
2019 20
2020 31
2021 17
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

845 results

Results by year

Filters applied: . Clear all
Page 1
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.
Skokos D, Waite JC, Haber L, Crawford A, Hermann A, Ullman E, Slim R, Godin S, Ajithdoss D, Ye X, Wang B, Wu Q, Ramos I, Pawashe A, Canova L, Vazzana K, Ram P, Herlihy E, Ahmed H, Oswald E, Golubov J, Poon P, Havel L, Chiu D, Lazo M, Provoncha K, Yu K, Kim J, Warsaw JJ, Stokes Oristian N, Siao CJ, Dudgeon D, Huang T, Potocky T, Martin J, MacDonald D, Oyejide A, Rafique A, Poueymirou W, Kirshner JR, Smith E, Olson W, Lin J, Thurston G, Sleeman MA, Murphy AJ, Yancopoulos GD. Skokos D, et al. Sci Transl Med. 2020 Jan 8;12(525):eaaw7888. doi: 10.1126/scitranslmed.aaw7888. Sci Transl Med. 2020. PMID: 31915305
CD28: A New Drug Target for Immune Disease.
Xia S, Chen Q, Niu B. Xia S, et al. Curr Drug Targets. 2020;21(6):589-598. doi: 10.2174/1389450120666191114102830. Curr Drug Targets. 2020. PMID: 31729942 Review.
Targeting CD28 to prevent transplant rejection.
Yeung MY, Najafian N, Sayegh MH. Yeung MY, et al. Expert Opin Ther Targets. 2014 Feb;18(2):225-42. doi: 10.1517/14728222.2014.863875. Epub 2013 Dec 12. Expert Opin Ther Targets. 2014. PMID: 24329604 Review.
CD28: direct and critical receptor for superantigen toxins.
Kaempfer R, Arad G, Levy R, Hillman D, Nasie I, Rotfogel Z. Kaempfer R, et al. Toxins (Basel). 2013 Sep 9;5(9):1531-42. doi: 10.3390/toxins5091531. Toxins (Basel). 2013. PMID: 24022021 Free PMC article. Review.
CD28 negative T cells: is their loss our gain?
Mou D, Espinosa J, Lo DJ, Kirk AD. Mou D, et al. Am J Transplant. 2014 Nov;14(11):2460-6. doi: 10.1111/ajt.12937. Epub 2014 Oct 16. Am J Transplant. 2014. PMID: 25323029 Free PMC article. Review.
CD28/B7 costimulation: a review.
Greenfield EA, Nguyen KA, Kuchroo VK. Greenfield EA, et al. Crit Rev Immunol. 1998;18(5):389-418. doi: 10.1615/critrevimmunol.v18.i5.10. Crit Rev Immunol. 1998. PMID: 9784967 Review.
845 results